Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+ T Cell Help

We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion of highly cytolytic, antigen-independent “bystander-activated” (CD8(+)CD44(high)) T cells displaying a CD25(−)NKG2D(+) phenotype in a cytokin...

Descripción completa

Detalles Bibliográficos
Autores principales: Monjazeb, Arta M., Tietze, Julia K., Grossenbacher, Steven K., Hsiao, Hui-Hua, Zamora, Anthony E., Mirsoian, Annie, Koehn, Brent, Blazar, Bruce R., Weiss, Jonathan M., Wiltrout, Robert H., Sckisel, Gail D., Murphy, William J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131875/
https://www.ncbi.nlm.nih.gov/pubmed/25119341
http://dx.doi.org/10.1371/journal.pone.0102709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131875/
https://www.ncbi.nlm.nih.gov/pubmed/25119341
http://dx.doi.org/10.1371/journal.pone.0102709

Ejemplares similares